Pub. Date : 2021 Jun
PMID : 33820447
1 Functional Relationships(s)Download |
Sentence | Compound Name | Protein Name | Organism |
| 1 | Among these, the PD-L1 inhibitor atezolizumab in combination with bevacizumab has reported unprecedented results in treatment-naive patients with unresectable disease, with the recently published IMbrave150 Phase III trial showing the superiority of the combination over sorafenib monotherapy, and after having attended more than a decade of "stagnation", the HCC medical community has a new standard of care. | Sorafenib | CD274 molecule | Homo sapiens |